![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](lh2592contents.gif)
Acta Cryst. (2008). E64, m411 [ doi:10.1107/S1600536808002328 ]
5-Cyclopentadienyl){[3-(2,2-dicyanoethenyl)bicyclo[2.2.1]hepta-2,5-dien-2-yl]ethynyl}(triphenylphosphine)nickel(II)Abstract: The title compound, [Ni(C5H5)(C13H7N2)(C18H15P)] or (
5-C5H5)(PPh3)Ni-C
C-C7H6-C(H)=C(CN)2, contains an unusual disubstituted norbornadienyl (NBD) ligand containing ethynyl (-C
C-) and dicyanovinyl [-C(H)=C(CN)2] groups. Disorder is present in the NBD group with site occupancies of 0.636 (10) and 0.364 (10) for two distinct orientations. There are no strong hydrogen bonds and the primary interactions are weak C-H
(arene) interactions.
Online 25 January 2008
Copyright © International Union of Crystallography
IUCr Webmaster